Publicaciones en las que colabora con Josep Mercader Barceló (5)

2020

  1. Opipramol inhibits lipolysis in human adipocytes without altering glucose uptake and differently from antipsychotic and antidepressant drugs with adverse effects on body weight control

    Pharmaceuticals, Vol. 13, Núm. 3

2019

  1. Oral phenelzine treatment mitigates metabolic disturbances in mice fed a high-fat diet

    Journal of Pharmacology and Experimental Therapeutics, Vol. 371, Núm. 2, pp. 555-566

2018

  1. Metabolic effects of oral phenelzine treatment on high-sucrose-drinking mice

    International Journal of Molecular Sciences, Vol. 19, Núm. 10

2014

  1. Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice

    European Journal of Nutrition, pp. 1625-1635

2013

  1. Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells

    Journal of Physiology and Biochemistry, Vol. 69, Núm. 3, pp. 585-593